Drugs Made In America Acquisition Corp. (DMAA)
NASDAQ: DMAA · Real-Time Price · USD
10.06
+0.02 (0.20%)
Apr 24, 2025, 4:00 PM EDT - Market closed

DMAA Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024
Period Ending
Dec '24
Net Income
-0.48
Other Operating Activities
0.05
Change in Other Net Operating Assets
0.13
Operating Cash Flow
-0.3
Total Debt Issued
3.09
Total Debt Repaid
-2.23
Net Debt Issued (Repaid)
0.86
Issuance of Common Stock
0.06
Other Financing Activities
-0.62
Financing Cash Flow
0.3
Net Cash Flow
0
Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q